Page last updated: 2024-10-23

bisbenzimidazole and Acute Promyelocytic Leukemia

bisbenzimidazole has been researched along with Acute Promyelocytic Leukemia in 3 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guan, F1
Wang, H1
Shan, Y1
Zhang, D1
Zhao, Y1
Chen, Y1
Wang, Q1
Wang, M1
Feng, X1
Chen, JC1
Zhang, X1
Singleton, TP1
Kiechle, FL1
Saiko, P1
Horvath, Z1
Murias, M1
Handler, N1
Jaeger, W1
Erker, T1
Fritzer-Szekeres, M1
Szekeres, T1

Other Studies

3 other studies available for bisbenzimidazole and Acute Promyelocytic Leukemia

ArticleYear
Bigelovii A induces apoptosis of HL‑60 human acute promyelocytic leukaemia cells.
    Molecular medicine reports, 2013, Volume: 7, Issue:5

    Topics: Apoptosis; bcl-2-Associated X Protein; Bisbenzimidazole; Blotting, Western; Caspase 3; Cell Count; C

2013
Mitochondrial membrane potential change induced by Hoechst 33342 in myelogenous leukemia cell line HL-60.
    Annals of clinical and laboratory science, 2004,Autumn, Volume: 34, Issue:4

    Topics: Apoptosis; Benzimidazoles; Bisbenzimidazole; Cell Line, Tumor; Cell Survival; Dose-Response Relation

2004
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
    Nucleosides, nucleotides & nucleic acids, 2006, Volume: 25, Issue:9-11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Cell Cycle;

2006